Clinical Trial Update: Hypertension Prevention Trial (HPT) Feasibility Study [Phase 2]

View source ↗

Summary

The Hypertension Prevention Trial (HPT) feasibility study, a Phase 2 NHLBI trial, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Heart Disease
• Hypertension
• Obesity
• Vascular Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Phase 2 | Status: COMPLETED